image of zantac

Zantac Recalled: How You Might Be Affected

Ranitidine, commonly known by its brand name Zantac, was recalled by the FDA on April 1st, 2020 due to its containment of a carcinogenic substance called N-Nitrosodimethylamine (NDMA). Zantac is an antihistamine and antacid that is most commonly used to treat heartburn and other conditions that increase stomach acid, such as stomach ulcers or gastroesophageal reflux disorder (GERD). Although higher levels of NDMA in the drug were first discovered in September of 2019, the FDA did not announce their full recall of the product until April of 2020, potentially putting the users of Zantac at great risk of consuming carcinogenic substances. In this announcement the FDA requested for all Ranitidine medications to be withdrawn from prescription or over the counter use in the United States. So, how might the recall of Zantac affect you? Let's find out more.

Potential Risks of NDMA

NDMA is a known animal carcinogen and a probable human carcinogen that is commonly ingested in very small quantities in the diet and has been the subject of many recent research studies. However, if this impurity is present in large quantities in a substance it could potentially be very dangerous for consumers and could be linked to cancer diagnoses. The problematic presence of NDMA in Ranitidine was first discovered in 2019 by a company called Valisure that tested the medication in the context of simulated stomach conditions. During this study, researchers found that when Ranitidine, brand-named Zantac, is combined with the gastric fluids and sodium nitrates found in the stomach, it produces dangerously high levels of NDMA. Valisure found the product to result in approximately 304,500 nanograms per tablet, greatly exceeding the FDA's acceptable intake amount of 96 nanograms per day.

Exposure to NDMA in Ranitidine can possibly lead to several types of cancers, including:

- Prostate cancer

- Esophageal cancer

- Stomach cancer

- Cancer of the small and large intestines

- Colorectal cancer

- Kidney cancer

- Liver cancer

- Bladder cancer

- Pancreatic cancer

- Leukemia

- Non-Hodgkins lymphoma

- Multiple myeloma

Although the main negative effect of excessive levels of NDMA is cancer, there are many other long-term and short-term conditions that past-users might face, including:

- Primary pulmonary hypertension

- Crohn's disease

- Liver failure or reduced liver function

- Reduced kidney function

- Reduced lung function

- Enlarged liver

- Jaundice

- Hair loss

- Hepatitis

- Vitamin B-12 deficiency

- Reduced platelet levels

- Cardiac arrhythmia (irregular heartbeat)

- Nervous system problems

- Elevated pneumonia risks

- Fever

- Nausea and vomiting

- Stomach cramps, constipation, and/or diarrhea

- Dizziness, drowsiness, and/or sleep problems

- Headaches

- Tender breasts (in males)

- Decreased Sex Drive

- Scarring and Fibrosis of the Liver

If you are a past user of Zantac or generic brand-named Ranitidine and experience any of these symptoms or have had a recent cancer diagnosis, you may be eligible to file claims.

Put Us On Your Side

  • Please enter your first name.
  • Please enter your last name.
  • Please enter your phone number.
    This isn't a valid phone number.
  • Please enter your email address.
    This isn't a valid email address.
  • Please make a selection.
  • Please enter a message.